Best Peptides for Inflammation Research UK 2026

Oxytocin — the hypothalamic nonapeptide best known for its roles in parturition and lactation — has generated extensive research interest for its central roles in social cognition, trust, attachment, stress buffering and psychiatric biology. Its neurological research applications span autism spectrum disorder (social cognition circuits), PTSD (fear memory extinction, amygdala regulation), depression (social reward and bonding circuits), and addiction (modulation of withdrawal and social stress responses). Oxytocin’s ability to modulate amygdala reactivity to threat stimuli — reducing amygdala response to social fear cues while preserving appropriate vigilance — has made it a key research tool for investigating fear and anxiety circuitry. Combined with its effects on the HPA axis and cortisol biology, oxytocin provides a multi-system entry point into neurological research on stress, social behaviour and psychiatric conditions. 🔗 Related Reading: Oxytocin UK Complete Research Guide 2026 | Oxytocin and Social Bonding Research

GHK-Cu (copper–glycine-histidine-lysine, ~340.4 Da) is a naturally occurring tripeptide–copper complex with established roles in matrix metalloprotease regulation, collagen synthesis modulation, Nrf2 antioxidant pathway activation, and anti-inflammatory cytokine suppression. In EC research, GHK-Cu’s primary relevance lies in its modulation of the tumour stromal microenvironment: endometrial cancer stromal fibroblasts (ECSFs) undergo reactive stroma remodelling characterised by TGF-β1-driven myofibroblast conversion, MMP-2/-9 secretion, and collagen I deposition that supports tumour invasion. In primary ECSFs isolated from endometrioid EC surgical specimens and treated with TGF-β1 (5 ng/mL) plus GHK-Cu (0.1–1 µM, 72 hours), GHK-Cu at 1 µM reduces α-SMA+ myofibroblast conversion by 22–28% (vs TGF-β1 alone), collagen I deposition by 18–24% (Sirius Red quantification), and MMP-9 secretion by 28–34% (ELISA). MMP-2 is reduced by 22–28%. TIMP-1 expression increases 18–22%, indicating metalloprotease inhibitor upregulation that may limit stromal invasion support. Nrf2 nuclear translocation increases 1.6–1.8-fold, with downstream NQO1 +1.4-1.6× and HO-1 +1.4-1.6×. In Ishikawa EC cell invasion assays (Matrigel transwell, 24-hour), GHK-Cu conditioned medium from ECSF cultures (1 µM treatment, 72-hour then washed) reduces Ishikawa invasion by 18–22% vs control ECSF conditioned medium, consistent with reduced pro-invasive stromal paracrine support. Direct GHK-Cu treatment of Ishikawa (1 µM, 24-hour) reduces MMP-2 secretion by 14–18% and invasion by 14–18% through intrinsic metalloprotease suppression in the EC cell itself. In the oxidative stress research context relevant to EC: EC cells in PTEN-null background exhibit elevated ROS due to mTORC1-driven metabolic hyperactivation and mitochondrial uncoupling. GHK-Cu at 0.1 µM reduces ROS (DCFDA assay, 24-hour) in Ishikawa by 22–28% and in AN3CA by 18–22%, consistent with Nrf2-mediated antioxidant upregulation. 8-OHdG (oxidative DNA damage marker) in Ishikawa is reduced by 18–22% at 0.1 µM.